High expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastoma

Erythropoietin (EPO) is used to treat anemia in neoplastic disease. EPO also exerts neuroprotective effects on neuronal cells, making a prophylactic use against the neurocognitive effects of radiochemotherapy probable. However, EPO/EPO-receptor (EPOR) signalling has been also detected in glioblastom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: BRUNOTTE, J., BOCK, H.C., BRÜCK, W., HEMMERLEIN, B., STRIK, H.
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440671/
https://ncbi.nlm.nih.gov/pubmed/22977501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.198
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados